Systemic Therapy for Metastatic Renal-Cell Carcinoma.

Christopher B. Allard, Francisco Gelpi-Hammerschmidt, Lauren C. Harshman, Toni K. Choueiri, Izak Faiena, Parth Modi, Benjamin I. Chung, Ilker Tinay, Eric A. Singer, Steven L. Chang, Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States. Urologic Oncology-seminars and Original Investigations. ,vol. 33, pp. 4- 6 ,(2015) , 10.1016/J.UROLONC.2015.06.014

E. Diamond, A.M. Molina, M. Carbonaro, N.H. Akhtar, P. Giannakakou, S.T. Tagawa, D.M. Nanus, Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy Critical Reviews in Oncology Hematology. ,vol. 96, pp. 518- 526 ,(2015) , 10.1016/J.CRITREVONC.2015.08.007

Julien Calderaro, Julien Moroch, Gaelle Pierron, Florence Pedeutour, Camille Grison, Pascale Maillé, Pascale Soyeux, Alexandre de la Taille, Jérome Couturier, Annick Vieillefond, Marie Christine Rousselet, Olivier Delattre, Yves Allory, SMARCB1/INI1 inactivation in renal medullary carcinoma. Histopathology. ,vol. 61, pp. 428- 435 ,(2012) , 10.1111/J.1365-2559.2012.04228.X

Eric Jonasch, Lincy S. Lal, Bradley J. Atkinson, Stacey DaCosta Byfield, Lesley Ann Miller, Lance C. Pagliaro, Chun Feng, Nizar M. Tannir, Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre. BJUI. ,vol. 107, pp. 741- 747 ,(2011) , 10.1111/J.1464-410X.2010.09626.X

L Zhou, X-D Liu, M Sun, X Zhang, P German, S Bai, Z Ding, N Tannir, C G Wood, S F Matin, J A Karam, P Tamboli, K Sircar, P Rao, E B Rankin, D A Laird, A G Hoang, C L Walker, A J Giaccia, E Jonasch, Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma Oncogene. ,vol. 35, pp. 2687- 2697 ,(2016) , 10.1038/ONC.2015.343

J P Kavolius, D P Mastorakos, C Pavlovich, P Russo, M E Burt, M S Brady, Resection of metastatic renal cell carcinoma. Journal of Clinical Oncology. ,vol. 16, pp. 2261- 2266 ,(1998) , 10.1200/JCO.1998.16.6.2261

Daniel Y. C. Heng, Toni K. Choueiri, Non-clear cell renal cancer: features and medical management. Journal of The National Comprehensive Cancer Network. ,vol. 7, pp. 659- 665 ,(2009) , 10.6004/JNCCN.2009.0046

M. Dror Michaelson, Rana R. McKay, Lillian Werner, Michael B. Atkins, Eliezer M. Van Allen, Kara M. Olivier, Jiaxi Song, Sabina Signoretti, David F. McDermott, Toni K. Choueiri, Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma. Cancer. ,vol. 121, pp. 3435- 3443 ,(2015) , 10.1002/CNCR.29503

A. Ravaud, S. Oudard, M. De Fromont, C. Chevreau, G. Gravis, S. Zanetta, C. Theodore, M. Jimenez, E. Sevin, B. Laguerre, F. Rolland, M. Ouali, S. Culine, B. Escudier, First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG) Annals of Oncology. ,vol. 26, pp. 1123- 1128 ,(2015) , 10.1093/ANNONC/MDV149

David F. McDermott, Su-Chun Cheng, Sabina Signoretti, Kim A. Margolin, Joseph I. Clark, Jeffrey A. Sosman, Janice P. Dutcher, Theodore F. Logan, Brendan D. Curti, Marc S. Ernstoff, Leonard Appleman, Michael K.K. Wong, Nikhil I. Khushalani, Leslie Oleksowicz, Ulka N. Vaishampayan, James W. Mier, David J. Panka, Rupal S. Bhatt, Alexandra S. Bailey, Bradley C. Leibovich, Eugene D. Kwon, Fairooz F. Kabbinavar, Arie S. Belldegrun, Robert A. Figlin, Allan J. Pantuck, Meredith M. Regan, Michael B. Atkins, The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma. Clinical Cancer Research. ,vol. 21, pp. 561- 568 ,(2015) , 10.1158/1078-0432.CCR-14-1520